tiprankstipranks
Trending News
More News >
Advertisement
Advertisement

Bristol-Myers backs FY23 adjusted EPS view $7.95-$8.25, consensus $8.06

Backs FY23 revenue view of increase by approximately 2% at reported rates and approximately 2% excluding foreign exchange, consensus $46.84B.

Elevate Your Investing Strategy:

  • Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.

Published first on TheFly

See today’s best-performing stocks on TipRanks >>

Read More on BMY:

Disclaimer & DisclosureReport an Issue

1